opinion
[대역어] None
[용어속성] Term
[용어속성] Term
Reports of Forgone Medical Care Among US Adults During the Initial Phase of the COVID-19 Pandemic
Research
[키워드] acute respiratory syndrome
age
black
Care
cause
caused
Characteristics
coronavirus
coronavirus disease
Coverage
COVID-19
COVID-19 case
COVID-19 pandemic
defined
dose
exposure
finding
Frequency
Health
Health status
Hispanic
Importance
IMPROVE
individual
initial
instance
Johns Hopkin
life
measure
Medicare
mental health
National
objective
Older
opinion
pandemic
Panel
participant
Participants
phase
Point
Policy
Primary outcome
Public
Relevance
report
reported
respondent
Result
SARS-CoV-2
SARS-CoV-2 transmission
second wave
setting
survey
Transmission
used data
white
women
[DOI] 10.1001/jamanetworkopen.2020.34882 PMC 바로가기 [Article Type] Research
[DOI] 10.1001/jamanetworkopen.2020.34882 PMC 바로가기 [Article Type] Research
Unfolding the Determinants of COVID-19 Vaccine Acceptance in China
Original Paper
[키워드] acceptance
accounted
addition
Affordability
analyzed
any other vaccine
candidate
China
Chinese
claimed
collected
communication
contrary
COVID-19
COVID-19 vaccination
COVID-19 vaccine
COVID-19 vaccines
determinant
develop
Efficacy
evidence communication
examined
FIVE
global effort
Government
human clinical trial
Inactivated vaccine
Inactivated Vaccines
include
individual
investigated
less
media
Meta-analysis
misunderstanding
MOST
objective
opinion
positive
promotion
Reflecting
responses
Result
risk
Risk communication
Side effect
Side effects
social media
Strategy
the vaccine
thought
Transmission
vaccination
Vaccine
Vaccine development
Vaccines
[DOI] 10.2196/26089 PMC 바로가기 [Article Type] Original Paper
[DOI] 10.2196/26089 PMC 바로가기 [Article Type] Original Paper
Double-blind, randomized, controlled, trial to assess the efficacy of allogenic mesenchymal stromal cells in patients with acute respiratory distress syndrome due to COVID-19 (COVID-AT): A structured summary of a study protocol for a randomised controlled trial
COVID-19(COVID-AT)로 인한 급성 호흡 곤란 증후군 환자에서 동종 간엽 기질 세포의 효능을 평가하기 위한 이중 맹검, 무작위, 대조 시험: 무작위 대조 시험을 위한 연구 프로토콜의 구조화된 요약
Letter
[키워드] 1:1
24 hours
7-point ordinal scale
acute respiratory distress
acute respiratory distress syndrome
Administered
administration
Admission
Adult patient
Adult patients
Adverse
Adverse drug reactions
AEs
age
All trial participants
all-cause mortality
allergy
Allogeneic
ARDS
assessment
assigned
baseline
Biomarker
blinded
Blinding
C-reactive protein
carcinoma
carcinoma in situ
carried
cellular
chain
change
childbearing potential
Chloroquine
Clinical practice
clinical status
clinical trial
coagulation test
coagulation tests
conducted
Control
control arm
Course
COVID
COVID-19
CRF
criteria
CT scan
cumulative incidence
current
Cytokines
D-dimer
Day
death
described
determined by
Diagnosis
disease
dissemination
double-blind
drug
Duration
ECMO
Efficacy
Efficacy and safety
element
eligible
End
endpoints
enrolment
EudraCT
evaluate
evaluate the effect
event
exclusion criteria
Extracorporeal
extracorporeal membrane oxygenation
failure
ferritin
fibrosis
FiO2
form
GRADE
grade 3
greater
Haemodialysis
handling
hemofiltration
history
hospital
Hospitalization
hydroxy
ICU
ICU admission
IMPROVE
include
inclusion criteria
Informed consent
intravenous
Intravenous administration
intravenous dose
intubation
Invasive mechanical ventilation
invasive ventilation
investigational medicinal product
involved
laboratory confirmation
laboratory-confirmed SARS-CoV-2 infection
lactation
LDH
less
Level
Local
Lopinavir
Lopinavir/ritonavir
lung disorder
lymphocyte
marker
Mechanical
mechanical ventilation
Medicine
Medicines
Mesenchymal stromal cells
moderate to severe
Mortality
MSC
negative pregnancy test
neoplasm
neutrophil
neutrophil counts
Non-invasive
number
objective
occur
off-label
opinion
Ordinal Scale
organ
oropharyngeal swab
oropharyngeal swabs
Other
outcome
oxygen
oxygen saturation
Oxygen therapy
PaO2
PaO2/FiO2 ratio
parameters
participant
Patient
PCR
percentage
Placebo
polymerase chain reaction
Pregnancy
primary endpoint
product
Production
profile
progression
protocol
Pulmonary embolism
pulmonary fibrosis
Pulmonary function tests
randomised
randomised controlled trial
randomization
Randomized
Randomly
Rapid antigen tests
reaction
receive
recruitment
Registered
Remdesivir
report
respiratory
Respiratory distress syndrome
Resuscitation
Ritonavir
SAEs
Sample size
SARS-COV-2 infection
secondary
Secondary endpoints
Sequential Organ Failure Assessment
Serious Adverse Events
SOFA
Spain
specificity
specimen
Sponsor
Standard of care
status
stromal cell
stromal cells
Study protocol
subpopulations
supplemental oxygen
supplementary material
syndrome
the cell
the disease
the patient
the primary endpoint
the WHO
time
Tocilizumab
Tolerability
Treatment
treatment arm
treatment for COVID-19
treatment group
Treatment protocol
Trial
trial participant
Trial registration
unit
website
women
worldwide pandemic
written consent
[DOI] 10.1186/s13063-020-04964-1 PMC 바로가기 [Article Type] Letter
[DOI] 10.1186/s13063-020-04964-1 PMC 바로가기 [Article Type] Letter
Slaying SARS-CoV-2 One (Single-domain) Antibody at a Time
Review article
[키워드] affinities
antibody
binding
binding affinity
biodistribution
complex
COVID-19
element
highlight
Immunoglobulin
IMPROVE
Novel coronavirus
opinion
Protein
RBD
SARS-CoV-2
Specificities
spike
target
the receptor-binding domain
the SARS-CoV-2
time
yeast
[DOI] 10.1016/j.tim.2020.12.006 [Article Type] Review article
[DOI] 10.1016/j.tim.2020.12.006 [Article Type] Review article
Nebulised surfactant for the treatment of severe COVID-19 in adults (COV-Surf): A structured summary of a study protocol for a randomized controlled trial
성인의 중증 COVID-19 치료를 위한 분무형 계면활성제(COV-Surf): 무작위 대조 시험을 위한 연구 프로토콜의 구조화된 요약
Randomized Controlled Trial
[키워드] 1080
24 hour
24 hours
48 hour
48 hours
ACE2
ADEs
administration
Adverse
adverse event
adverse events
AEs
ALEA
All participant
All participants
allergy
alveolar
angiotensin
angiotensin converting enzyme
angiotensin converting enzyme 2
anticipated
attending physician
bind
Blinding
block randomization
Blood
bovine
breath
buffer
calcium
cells
cellular
cholesterol
Chronic kidney disease
class
clinical
Clinical improvement
clinical trial
clinical trials
Cohort
Combination
comparator
Compliance
Concentration
conducted
Consent
contraindication
contributing to
Control
control arm
controls
COVID-19
COVID-19 adult patient
COVID-19 patients
current
cytokine
Data collection
Data monitoring committee
death
declined
defined
delivery
described
Device
dialysis
discretion
dissemination
dose
drug
Effect
Efficacy
EGFR
element
Eligible participants
end point
End-Expiratory Pressure
Endotracheal intubation
enrolled
Enrollment
enrolment
epithelial
Escalation
EudraCT
evaluate
exclusion
exclusion criteria
expected
fatty
Fatty acid
feasibility
free fatty acid
Frequency
hospital
hospitalised
hypoxia
impair
include
inclusion criteria
index
Inflammatory marker
inflammatory markers
Inflammatory response
intensive care
intensive care unit
Intervention
investigator
Kidney disease
lack
liver
liver failure
Local
lung
lung lavage
mechanical ventilation
mechanical ventilator
mechanically ventilated patient
mechanically ventilated patients
mixture
Mortality
nebulisation
number
objective
Open-label
opinion
Ordinal Scale
other treatment
outcome
oxidative stress
Oxygenation
PaO
participant
Patient
PCR
PEEP
Phosphatidylcholine
phosphatidylethanolamine
phosphatidylglycerol
phosphatidylinositol
phospholipid
PIP
Placebo
plasma
Pneumothorax
Positive end-expiratory pressure
Prevent
Primary outcome
progression
Protein
protocol
pulmonary compliance
pulmonary hemorrhage
pulmonary ventilation
quantification
randomisation
randomised
randomised controlled trial
Randomized
Randomized controlled trial
reached
receive
recorded
recruitment
reduction
Registered
reported
Respiratory failure
SAEs
Sample size
SARS-CoV-2 viral load
SARS-CoV-2 virus
secondary outcome
Secondary outcomes
Serious Adverse Events
severe COVID-19
severity
sphingomyelin
Stage
Standard
Standard of care
status
Study protocol
subject
supplementary material
surface tension
surfactant
synthesis
tension
the WHO
tissue damage
total sample size
tracheal
tracheal aspirate
Tracheal aspirates
transfer
Treatment
Trial
Trial Steering Committee
turnover
unique
university
University College London
usual standard of care
Ventilation
Ventilation Index
ventilatory support
VFD
vibrating mesh nebulizer
Viral
Viral load
virus
water
website
weight
with COVID-19
worsening
[DOI] 10.1186/s13063-020-04944-5 PMC 바로가기 [Article Type] Randomized Controlled Trial
[DOI] 10.1186/s13063-020-04944-5 PMC 바로가기 [Article Type] Randomized Controlled Trial
Hydroxychloroquine for prophylaxis of COVID-19 physicians survey: Despite lack of evidence, many would take or give to dear ones, and despite the perceived necessity of an RCT, few would participate
코로나19 예방을 위한 하이드록시클로로퀸 내과의사 설문조사: 근거 부족에도 불구하고 많은 사람이 소중한 사람에게 받거나 주고, RCT의 필요성 인식에도 불구하고 소수 참여
Article
[키워드] administer
age
asked
belief
Care
collected
concerning
Controlled trial
correlation
COVID-19
COVID-19 patients
Evidence
Facebook
family
Hydroxychloroquine
indicated
information
involved
lack
opinion
patients
performed
physician
Physicians
prophylactically
Prophylaxis
questionnaire
Randomized
randomized clinical trial
Randomized controlled trial
RCT
survey.
thought
Treatment
treatment for COVID-19
treatment regimen
Trial
use of hydroxychloroquine
[DOI] 10.1111/jep.13484 PMC 바로가기 [Article Type] Article
[DOI] 10.1111/jep.13484 PMC 바로가기 [Article Type] Article
Coronavirus Disease 2019 (COVID-19) Spread and Pharmacovigilance Implications: Expert Opinion
코로나바이러스 질병 2019(COVID-19) 확산 및 약물감시 영향: 전문가 의견
Editorial
[키워드] approved
China
Chloroquine
clinical trial
Community
condition
consequence
coronavirus disease
Coronavirus disease 2019
Coronaviruses
COVID-19
expert
Healthcare systems
Hydroxychloroquine
in viral
in vitro study
individual
Infection
Infection prevention
management
measure
Medicine
opinion
other conditions
Patient
pharmacovigilance
Pharmacovigilance.
Pharmacy
physician
pressure
Prevention and control
resulting
supportive care
therapy
Toxicity
Treatment
treatments for COVID-19
viable treatment
Viral
Viral resistance
[DOI] 10.1007/s43441-020-00158-8 PMC 바로가기 [Article Type] Editorial
[DOI] 10.1007/s43441-020-00158-8 PMC 바로가기 [Article Type] Editorial
Safe management of surgical smoke in the age of COVID-19
코로나19 시대의 안전한 수술연기 관리
Review
[키워드] Affect
age
analysed
best
choice
Combination
COVID-19
COVID-19 pandemic
COVID-19 transmission
Device
equipment
Evidence
global pandemic
Guidance
hazard
hazards
healthcare
higher risk
invasive
knowledge
Laparoscopic surgery
management
minimally invasive surgery
mitigate
not need
Novel coronavirus
Operating room
operating theatre
opinion
Patient
plethora
pneumoperitoneum
potential risk
produced
producing
protocol
provide
raise
Result
risk
smoke
surgeon
surgical
theoretical risk
Transmission
virus
virus transmission
[DOI] 10.1002/bjs.11679 PMC 바로가기 [Article Type] Review
[DOI] 10.1002/bjs.11679 PMC 바로가기 [Article Type] Review
Essential, not peripheral: Addressing health care workers’ mental health concerns during the COVID‐19 pandemic
Opinion
[키워드] Care
conditions
COVID‐19
COVID‐19
Essential
Evidence
Health
Health care worker
health care workers
Impact
mental health
mental health concern
opinion
pandemic
Psychological distress
suffered
Topic
[DOI] 10.1002/1348-9585.12169 PMC 바로가기 [Article Type] Opinion
[DOI] 10.1002/1348-9585.12169 PMC 바로가기 [Article Type] Opinion